D A Bull Selected Research

Myocardial Ischemia (Ischemic Heart Diseases)

1/2009	Polymeric gene delivery of ischemia-inducible VEGF significantly attenuates infarct size and apoptosis following myocardial infarct.
9/2003	Hypoxia-inducible VEGF gene delivery to ischemic myocardium using water-soluble lipopolymer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

D A Bull Research Topics

Disease

2	Infections 08/2021 - 12/2020
2	Chronic Obstructive Pulmonary Disease (COPD) 08/2021 - 12/2020
2	COVID-19 08/2021 - 12/2020
2	Myocardial Ischemia (Ischemic Heart Diseases) 01/2009 - 09/2003
1	Ischemia 01/2009
1	Infarction (Infarctions) 01/2009
1	Myocardial Infarction 01/2009
1	Atherosclerotic Plaque (Atheroma) 09/2003
1	Neoplasms (Cancer) 09/2003
1	Pathologic Neovascularization 09/2003
1	Rupture 09/2003
1	Cardiovascular Diseases (Cardiovascular Disease) 09/2003
1	Hypoxia (Hypoxemia) 09/2003
1	Carcinoma (Carcinomatosis) 12/2000
1	Reperfusion Injury 02/2000

Drug/Important Bio-Agent (IBA)

2	Angiotensin-Converting Enzyme 2IBA 08/2021 - 12/2020
2	SmokeIBA 08/2021 - 12/2020
2	Messenger RNA (mRNA)IBA 08/2021 - 12/2020
2	Proteins (Proteins, Gene)FDA Link 12/2020 - 09/2003
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2009 - 09/2003
2	poly(ethylenimine)-co-(N-(2-aminoethyl) ethyleneimin)- co- N- (N- cholesteryloxycarbonyl- (2- aminoethyl)ethylenimine)IBA 01/2009 - 09/2003
1	Peptide Hydrolases (Proteases)FDA Link 12/2020
1	Erythropoietin FDA Link 09/2003
1	Prostaglandins AIBA 12/2000
1	CytokinesIBA 02/2000
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2000

Therapy/Procedure

1	Ligation 01/2009
1	Therapeutics 01/2009